Zealand Pharma A/S ZEAL-DK:Copenhagen Stock Exchange

RT Quote | Exchange | DKK
Last | 03/05/21 CET
191.10quote price arrow down-5.20 (-2.65%)
Volume
179,330
52 week range
189.40 - 237.00

...

Loading . . .

KEY STATS

  • Open196.00
  • Day High196.30
  • Day Low189.70
  • Prev Close196.30
  • 52 Week High237.00
  • 52 Week High Date01/12/21
  • 52 Week Low189.40
  • 52 Week Low Date02/23/21
  • Market Cap1,218.8M
  • Shares Out39.71M
  • 10 Day Average Volume134,683.73
  • Dividend-
  • Dividend Yield-
  • Beta1
  • 1 Year % Change-26.61

RATIOS/PROFITABILITY

  • EPS (TTM)-17.50
  • P/E (TTM)-10.92
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Zealand Pharma A/S News

There is no recent news for this security.

Latest ZEAL-DK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Zealand Pharma A/S is a Denmark-based biopharmaceutical company engaged in the discovery, development and commercialization of peptide-based medicines. The Company's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and Danegaptide. The Other indications area offers ZP1848, Elsiglutide and...
Alf Nicklasson Ph.D.
Chairman
Kirsten Drejer
Vice Chairman
Emmanuel Dulac Pharm.D.
President
Matthew Dallas
Chief Financial Officer
Adam Steensberg M.D.
Executive Vice President
Address
Sydmarken 11
Soeborg
2860
Denmark